Deflazacort in giant cell arteritis.
Devogelaer
Jean-Pierre
JP
Gennari
Carlo
C
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects; D001851:Bone Diseases, Metabolic / Q000139:chemically induced; D002112:Calcifediol / Q000008:administration & dosage; D019587:Dietary Supplements; D004305:Dose-Response Relationship, Drug; D013700:Giant Cell Arteritis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011241:Prednisone / Q000009:adverse effects; D011282:Pregnenediones / Q000008:administration & dosage / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic
D000893:Anti-Inflammatory Agents; D011282:Pregnenediones; C021988:deflazacort; D002112:Calcifediol; D011241:Prednisone